Facebook
Twitter
LinkedIn
Forward
VIRTUAL REGISTRATION: Child & Adolescent Psychopharmacology 2024
We invite you to join us Virtually for our Child & Adolescent Psychopharmacology 2024 Conference!
Please Note: The conference will be held in Eastern Daylight Time (EDT)
Complex challenges and evolving guidelines are changing the way you care for young psychiatric patients. These areas include new diagnostic criteria, patient-centered care models, new trends in substance abuse, research advances on genetics, and much more. It is more important than ever to find education that not only covers all these topics, but is also innovative, engaging, and empowers you to reach improved outcomes.
That's why it's critical to attend this hands-on, comprehensive conference. It provides psychiatrists, pediatricians, primary care and family practice physicians, nursing professionals, psychologists, social workers, and other mental health professionals with insights to optimize your assessment, treatment, and management of child and adolescent patients with psychiatric conditions.
- Meet and engage with renowned clinician-researchers who share the latest advances in their fields
- Find guidance for complex signs and symptoms such as emotional outbursts, mood swings, and strange eating habits that can be indicative of psychiatric disorders yet can also be part of normal child development
- Translate the latest research into optimal assessment and treatment strategies for anxiety, substance abuse, depression, eating disorders, OCD, psychosis, and much more
You will receive an email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the zoom instructions and attending virtually.
Pricing
MDs/Doctoral-Level Professionals
Regular Registration (after February 15, 2024): $995
Other Professionals or Trainees
Regular Registration (after February 15, 2024): $895
Live Registration:
The conference occurs live at the Westin Copley Place in Boston. For more information about in-person attendance and the venue, please visit our live registration page:
Child & Adolescent Psychopharmacology 2024: Live Registration - Click Here
E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by February 16, 2024. No refunds will be issued for refund requests made after February 16, 2024. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.
Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition
Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.
Purchase a print copy of our Board Preparation book here!
Target Audience
- Psychiatrists
- Primary care and family practice physicians
- Pediatricians
- Psychologists
- Nursing professionals
- Social workers
- Residents
- Other mental health, primary care and pediatric clinicians
Learning Objectives
By the end of this program, participants will be able to:
- Recognize the presentation, diagnosis, and current treatment options available for attention deficit hyperactivity disorder in childhood and adolescence.
- Discuss the presentation, diagnosis, and current treatment options available for depression, psychosis, bipolar disorder, and anxiety.
- Discuss the available naturopathic treatments for emotional dysregulation in youth, including pros, cons, and available evidence.
- Examine the evidence base for the Pediatric Autoimmune Neurological Disorder Associated with Streptococcus symptoms and its relation to OCD.
- Compare and contrast psychotherapeutic treatment approaches for children including DBT, CBT, and others.
Child & Adolescent Psychopharmacology
March 8-10, 2024 (Eastern Daylight Time)
Westin Copley Place, Boston, MA
FRIDAY MARCH 8, 2024
8:00 – 8:05 AM Welcome & Introduction
Janet Wozniak, MD
MODULE TOPIC 1: OVERVIEW OF PEDIATRIC PSYCHOPHARMACOLOGY
8:05 – 8:25 AM Diagnosis & Assessment in Pediatric Psychopharmacology
Janet Wozniak, MD
8:25 – 8:45 AM Implications of Psychiatric Genetics for Psychopharmacology Developmental Neuroscience
Stephen V. Faraone, PhD
8:45 – 9:05 AM Developmental Neuroscience
Joshua Roffman, MD
MODULE TOPIC 2: ADHD I
9:05 – 9:25 AM Diagnosis, Course and Outcomes of ADHD
Thomas Spencer, MD
9:25 – 9:45 AM Genetics of ADHD
Stephen V. Faraone, PhD
9:45 – 10:05 AM Treatment of ADHD with Stimulants I
Timothy E. Wilens, MD
10:05 – 10:25 AM Break
10:25 – 10:45 AM Treatment of ADHD with Stimulants II
Timothy E. Wilens, MD
10:45 – 11:05 AM Pharmacological Treatment of ADHD Across the Life Span: Nonstimulants
Thomas Spencer, MD
11:05 – 11:25 AM ADHD, Tics and Tourette’s Disorder
Erica Greenberg, MD
11:25 – 11:55 AM Question & Answer Panel
Moderator: Timothy E. Wilens, MD
Panelists: Thomas Spencer, MD, Stephen V. Faraone, PhD, Erica Greenberg, MD
11:55 – 12:55 PM Lunch Break
MODULE TOPIC 3: ADHD II
12:55 – 1:15 PM CBT & Psychosocial Treatments in ADHD
Aude Henin, PhD
1:15 – 1:35 PM ADHD & Education
Aude Henin, PhD
1:35 – 1:55 PM Functional Outcomes in ADHD and the Critical Importance of Treatment to Mitigate Them
Timothy E. Wilens, MD
1:55 – 2:25 PM Question & Answer Panel
Moderator: Timothy Wilens, MD
Panelists: Aude Henin, PhD
2:25 – 2:45 PM Break
MODULE TOPIC 4: MOOD DISORDERS I
2:45 – 3:05 PM Pharmacological Approaches to Pediatric Mania
Janet Wozniak, MD
3:05 – 3:25 PM Schizophrenia Diagnosis and Treatment
Abigail Donovan, MD
3:25 – 3:45 PM Nutraceuticals in Pharmacology
Janet Wozniak, MD
3:45 – 4:15 PM Question & Answer Panel
Moderator: Janet Wozniak, MD
Panelist: Abigail Donovan, MD
4:15 PM Adjourn
SATURDAY, MARCH 9, 2024
8:00 – 8:05 AM Welcome & Introduction
David H. Rubin, MD
MODULE TOPIC 5: MOOD DISORDERS II
8:05 – 8:25 AM Juvenile Depression
Mai Uchida, MD
8:25 – 8:45 AM Illuminating the Black Box: Antidepressants, Youth and Suicide
David H. Rubin, MD
8:45 – 9:05 AM Neurotherapeutics
James Luccarelli, MD
9:05 – 9:25 AM Juvenile Mania
Janet Wozniak, MD
9:25 – 9:45 AM Differentiating Unipolar vs. Bipolar Mood Disorders in the Young
Mai Uchida, MD
9:45 – 10:05 AM Distinguishing Emotional Dysregulation from Mania
Janet Wozniak, MD
10:05 – 10:35 AM Question & Answer Panel
Moderator: David H. Rubin, MD
Panelists: Janet Wozniak, MD, James Luccarelli, MD, Mai Uchida, MD
10:35 – 10:55 AM Break
MODULE TOPIC 6: DIAGNOSIS, UNDERPINNINGS, AND TREATMENT OF AUTISM
10:55 – 11:15 AM Assessment, Prevalence and Presentation of Autism
Gagan Joshi, MD
11:15 – 11:35 AM Neural Underpinnings and Pharmacological Treatments of Autism I
Gagan Joshi, MD
11:35 – 11:55 AM Pharmacological Treatments of Autism II & Comorbidities
Robyn Thom, MD
11:55 – 12:15 PM Using Psychological Assessment to Inform Treatment
Ellen Braaten, MD
12:15 – 12:45 PM Question & Answer Panel
Moderator: Gagan Joshi, MD
Panelists: Robyn Thom, MD, Ellen Braaten, MD
12:45 – 1:45 PM Lunch Break
MODULE TOPIC 7: OCD, ANXIETY DISORDERS, TOURETTE’S, PANDAS
1:45 – 2:05 PM Tics and Tourette’s Disorder
Erica Greenberg, MD
2:05 – 2:25 PM Obsessive Compulsive Disorder
Dan Geller, MD
2:25 – 2:45 PM PANDAS
Kyle Williams, MD, PhD
2:45 – 3:05 PM Pediatric Anxiety Disorders
Erica Greenberg, MD
3:05 – 3:35 PM Question & Answer Panel
Moderator: Gagan Joshi, MD
Panelist: Erica Greenberg, MD, Dan Geller, MD, Kyle Williams, MD, PhD
3:35 PM Adjourn
SUNDAY, MARCH 10, 2024
8:00 – 8:05 AM Welcome & Introduction
Timothy E. Wilens, MD
MODULE TOPIC 8: PSYCHOLOGICAL ASSESSMENT & INTERVENTION
8:05 – 8:25 AM Cognitive Behavioral Treatment for Young Adults: Education & Psychological Testing
Aude Henin, PhD
8:25 – 8:45 AM Cognitive Behavioral Therapy for Anxiety in Young Children
Dina Hirshfeld-Becker, PhD
8:45 – 9:05 AM Integrating DBT in Clinical Practice
Makiko Watanabe, PhD
9:05 – 9:25 AM Integrating Resiliency in Everyday Practice
Aude Henin, PhD
9:25 – 9:55 AM Question & Answer Panel
Moderator: Aude Henin, PhD
Panelists: Dina Hirshfeld-Becker, PhD, Makiko Watanabe, PhD
9:55 – 10:15 AM Break
MODULE TOPIC 9: SUBSTANCE USE DISORDERS
10:15 – 10:35 AM Substance Use Disorders: Part I
Timothy E. Wilens, MD
10:35 – 10:55 AM Substance Use Disorders: Part II
Amy Yule, MD
10:55 – 11:15 AM Marijuana
Timothy E. Wilens, MD
11:15 – 11:45 AM Question & Answer Panel
Moderator: Timothy E. Wilens, MD
Panelists: Amy Yule, MD
11:45 AM Adjourn
Ellen Braaten, MD
Abigail Donovan, MD
Stephen V. Faraone, PhD
Dan Geller, MD
Erica Greenberg, MD
Aude Henin, PhD
Dina Hirshfeld-Becker, PhD
Gagan Joshi, MD
James Luccarelli, MD
Joshua Roffman, MD
David H. Rubin, MD
Thomas Spencer, MD
Robyn Thom, MD
Mai Uchida, MD
Makiko Watanabe, PhD
Timothy E. Wilens, MD
Kyle Williams, MD, PhD
Janet Wozniak, MD
Amy Yule, MD
The AAFP has reviewed Child and Adolescent Psychopharmacology 2024 and deemed it acceptable for up to 16.25 Live AAFP Prescribed credits. Term of Approval is from 03/08/2024 to 03/10/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Available Credit
- 16.25 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 16.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 16.25 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 16.25 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 16.25 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 16.25 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number
- 16.25 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 16.25 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 16.25 Continuing Education (CE) credits per presentation for psychologists.
Price
Accreditation
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
16.25 Psychologists:
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. MGH Institute of Health Professions designates this activity for 16.25 CE credit.
16.25 Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
The AAFP has reviewed Child and Adolescent Psychopharmacology 2024 and deemed it acceptable for up to 16.25 Live AAFP Prescribed credits. Term of Approval is from 03/08/2024 to 03/10/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
16.25 Nursing Contact Hours
MGH Institute of Health Professions designates this activity for 16.25 contact hours for nurses.
16.25 Social Workers
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 16.25 clock hours for continuing education credits.
16.25 IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 16.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
PHARMACISTS (ACPE)
This activity provides 14.00 contact hours (1.0 CEUs) of continuing education credit. ACPE Universal Activity Number UAN JA4008265-0000-24-003-L01-P/UAN JA4008265-0000-24-003-L01-T
NOTE FOR PHARMACISTS: Upon closing of the electronic evaluation, MGH IHP will upload the pharmacy-related continuing education information to CPE Monitor within 60 days. Per ACPE rules, MGH IHP does not have access nor the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP ePID and DOB (in MMDD format)] in order to receive credit for participating in a CE activity.